BIOAVAILABILITY IN MAN OF ATENOLOL AND CHLORTHALIDONE FROM A COMBINATION FORMULATION

被引：14

作者：

MCAINSH, J ^{[1
]}

BASTAIN, W ^{[1
]}

YOUNG, J ^{[1
]}

HARRY, JD ^{[1
]}

机构：

[1] ICI LTD, CLIN PHARMACOL UNIT, ALDERLEY PK, CHESHIRE, ENGLAND

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1981年 / 2卷 / 02期

关键词：

D O I：

10.1002/bdd.2510020207

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：147 / 156

页数：10

共 10 条

[1] PHARMACOLOGICAL EFFECTS AND SERUM LEVELS OF ORALLY ADMINISTERED ALPRENOLOL IN MAN [J].

ABLAD, B ;

HALLGREN, J ;

SOLVELL, L ;

JOHNSSON, G ;

ERVIK, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1972, 5 (01) :44-&

[2]

BAHR CV, 1976, CLIN PHARMACOL THER, V20, P130

[3]

HOFFBRAND BJ, 1977, POSTGRAD MED J S3, V53

[4] BIOAVAILABILITY OF ATENOLOL FORMULATIONS [J].

MCAINSH, J ;

SIMPSON, WT ;

HOLMES, BF ;

YOUNG, J ;

ELLIS, SH .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1980, 1 (06) :323-332

[5] BIOAVAILABILITY - PROBLEM IN EQUIVALENCE [J].

METZLER, CM .

BIOMETRICS, 1974, 30 (02) :309-317

[6] STEADY-STATE PLASMA CONCENTRATIONS OF ALPRENOLOL IN MAN [J].

RAWLINS, MD ;

COLLSTE, P ;

FRISKHOL.M ;

LIND, M ;

OSTMAN, J ;

SJOQVIST, F .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (05) :353-356

[7] PHARMACOKINETICS OF ATENOLOL IN HYPERTENSIVE SUBJECTS WITH AND WITHOUT CO-ADMINISTRATION OF CHLORTHALIDONE [J].

RIVA, E ;

FARINA, PL ;

SEGA, R ;

TOGNONI, G ;

BASTAIN, W ;

MCAINSH, J .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (05) :333-337

[8] GAS-CHROMATOGRAPHIC DETERMINATION OF ATENOLOL IN BIOLOGICAL SAMPLES [J].

SCALES, B ;

COPSEY, PB .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (06) :430-433

[9] PHARMACOKINETIC PROPERTIES OF BETA-ADRENERGIC-RECEPTOR BLOCKING-DRUGS [J].

SHAND, DG .

DRUGS, 1974, 7 (1-2) :39-47

[10]

SHAND DG, 1970, CLIN PHARMACOL THER, V11, P112

← 1 →